C

Conformis Inc
F:308

Watchlist Manager
Conformis Inc
F:308
Watchlist
Price: 1.21 EUR 7.08% Market Closed
Market Cap: €225.2m

Conformis Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Conformis Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
Conformis Inc
F:308
Revenue
$57.1m
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Revenue
$20.1B
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
10%
Edwards Lifesciences Corp
NYSE:EW
Revenue
$6.1B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
9%
Stryker Corp
NYSE:SYK
Revenue
$25.1B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Revenue
$45.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$10.1B
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
15%
No Stocks Found

Conformis Inc
Glance View

Market Cap
225.2m EUR
Industry
Health Care

ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. The company is headquartered in Billerica, Massachusetts and currently employs 310 full-time employees. The company went IPO on 2015-07-01. The firm is engaged in the development, manufacturing, and sales of patient-specific products and instrumentation that are individually sized and shaped to fit each patient's unique knee and hip anatomy. The Company’s products include iUni, iDuo, iTotal CR, iTotal PS, iTotal Identity, Identity Imprint and Conformis Cordera hip system. The Company’s iFit Image-to-Implant technology platform includes iFit Design, iFit Printing and iFit Just-in-Time Delivery. Its Identity Imprint knee system provides a data-informed knee implant system that provides a level of personalization through its patient-specific instruments (PSI) and proprietary algorithms for pre-surgical planning. Its Image-to-Implant Platinum Services program offering services in United States. The firm offers a line of the sterile, personalized knee and hip implants and single-use instruments delivered to hospitals.

Intrinsic Value
Not Available
C

See Also

What is Conformis Inc's Revenue?
Revenue
57.1m USD

Based on the financial report for Jun 30, 2023, Conformis Inc's Revenue amounts to 57.1m USD.

What is Conformis Inc's Revenue growth rate?
Revenue CAGR 5Y
-6%

Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Conformis Inc have been -8% over the past three years , -6% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett